Effects of non-steroidal anti-inflammatory drugs (NSAIDs) on human polymorphonuclear leucocyte function in buffer and plasma

Clinical and Experimental Rheumatology

Volumn 16, Issue 6, 1998, Pages 703-708

  Angelis Stoforidisl, P ^a   Vajda, R J E ^b   Christophidisl, N ^a  

^a ALFRED HOSPITAL   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

NSAID; Plasma; Polymorphonuclear leucocyte

Indexed keywords

BUFFER; DICLOFENAC; IBUPROFEN; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; PIROXICAM; PROSTAGLANDIN SYNTHASE; TENOXICAM;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; INFLAMMATION; IODINATION; PRIORITY JOURNAL; RESPIRATORY BURST;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUFFERS; CELLS, CULTURED; CHEMILUMINESCENT MEASUREMENTS; HUMANS; IODINE; LUMINOL; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PEROXIDASE; RESPIRATORY BURST; TETRADECANOYLPHORBOL ACETATE; ZYMOSAN;

EID: 0031732928     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. HARRIS ED Jr: Pathogenesis of rheumatoid arthritis. In KELLY WN, HARRIS ED Jr, RUDDY S, SLEDGE CD (Eds.): Textbook of Rheumatology. Philadelphia, W.B. Saunders, 1985: 886-915.
2. ABRAMSON S, EDELSON H, KAPLAN H, GIVEN W, WEISSMANN G: The neutrophil in rheumatoid arthritis: Its role and the inhibition of its activation by nonsteroidal anti-inflammatory drugs. Semin Arthritis Rheum 1983; 13 (Suppl 1): 148-53.
3. HURST NP: Molecular basis of activation and regulation of the phagocyte respiratory burst. Ann Rheum Dis 1987; 46: 265-272.
4. BABIOR BM, KIPNES RS, CURNUTTE JT: Biological defense mechanisms. The production by leukocytes of Superoxide, a potential bactericidal agent. J Clin Invest 1973 ; 52:741-4.
5. HOMAN-MULLER J\VT, WEENING RS, ROOS D: Production of hydrogen peroxide by phagocytosing human granulocytes. J Lab Clin Med 1975 ; 85:198-207.
6. ARNOLD WJ: The locomotor system: Rheumatoid arthritis. In RAKEL RE (Ed.): Conn 's Current Therapy. Philadelphia, W.B. Saunders 1988:831-4.
7. DAVIES J, SHEPPARD K, FLETCHER J: Inhibition of human neutrophil secondary granule discharge by anti-inflammatory agents. Inflammation 1984; 8:343-51.
8. BROWN KA, COLLINS AJ: In vitro effects of non-steroidal anti-inflammatory drugs on human polymorphonuclear cells and lymphocyte migration. BrJPharmacol 1978; 64:347-52.
9. SMITH MJH, WALKER JR: The effects of some antirheumatic drags on an in vitro model of human polymorphonuclear leukocyte chemokinesis. BrJ Pharmacol 1980; 69: 473-8.
10. FRIMAN C, JOHNSTON C, CHEW C, DAVIS P: Effect of diclofenac sodium, tolfenamic acid and indomethacin on the production of superoxide induced by N-formyl-methionyl-Ieucylphenylalanine in normal human polymorphonuclear leukocytes. Scand J Rheumatol 1986; 15: 41-6.
11. NIELSEN VG, WEBSTER RO: Inhibition of human polymorphonuclear leucocyte functions by ibuprofen. Immunopharmacology 1987; 13: 61-71.
12. MINTA JO, WILLIAMS MD: Some nonsteroidal antiinflammatory drags inhibit the generation of Superoxide anions by activated polymorphs by blocking ligand-receptor interactions. J Rheumatol 1985; 12: 751-7.
13. KU EC, LEE W, KOTHARI HV, SCHOLER DW: Effect of diclofenac sodium on the arachidonic acid cascade. Am JMed 1986; 80(4B): 18-23.
14. NIIRO H, OTSUKA T, IZUIIARA K et al.: Regulation by interleukin-10 and interIeukin-4 of cyclooxygenase-2 expression in human neutrophils. Blood 1997; 89:1621-8.
15. ABRAMSON S, EDELSON H, KAPLAN H, LUDE\VIG R, WEISSMANN G: Inhibition of neutrophil activation by nonsteroidal anti-inflammatory drags. AmJMed 1984; 77 (4B): 3-6.
16. FERIANIN A, GIROUD JP, HAKIM J: Stimulation of human polymorphonuclear leukocytes potentiates the uptake of diclofenac and the inhibition of chemotaxis. Biochem Pharmacol 1990; 40:2039-45.
17. KETTLE AJ, WINTERBOURN CC: Superoxide modulates the activity of myeloperoxidase and optimizes the production of hypochlorous acid. Biochem J 1988 ; 252:529-36.
18. SUEMATSU M, SUZUKI M, MIURA S et al.: Sulfasalazine and its metabolites attenuate respiratory burst of leukocytes -A possible mechanism of anti-inflammatory effects. J Clin Lab Immimol 1987; 23: 31-3.
19. MULLER-PEDDINGHAUS R, WURL M: The amplified chemiluminesccnce test to characterize antirheumatic drugs as oxygen radical scavengers. Biochem Pharmacol 1987; 36: 1125-32.
20. Tilcotil. In THOMAS J (Ed.): Australian Prescription Products Guide. Hawthorn, Vie., Australian Pharmaceutical Publishing Company Limited, 1998: 2744-6.
21. HOBBS DC, TWOMEY TM: Piroxicam pharmacokinetics in man: Aspirin and antacid interaction studies. J Clin Pharmacol 1979; 19: 270-81.
22. Ibuprofen. In MCEVOY GK et al., (Eds.): American Hospital Formulary Service Drug Information. Published by authority of the board of directors of the American Society of Health-System Pharmacists, 1998:1612-7.
23. Ketoprofen. In MCEVOY GK et al., (Eds.): American Hospital Formulary Service Drug Information. Published by authority of the board of directors of the American Society of Health-System Pharmacists, 1998: 1627-32.
24. FOWLER PD: Voltarol: Diclofenac sodium. Clin Rheum Dis 1979; 5: 427-64.
25. ROOT RK, STOSSEL TP: Myeloperoxidasemediated iodination by granulocytes. Intracellular site of operation and some regulating factors. J Clin Invest 1974; 53:1207-15.
26. SIMMONS SR, KARNOVSKY ML: lodinating ability of various leukocytes and their bactericidal activity. JExpMed 1973; 138:44-63.